Stockreport

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal [Yahoo! Finance]

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated by statistically significant improvement in health-related quality of li [Read more]